April 4, 2018

Subclinical Amyloid: Next Target for Alzheimer’s Trials? Research suggests negative PET amyloid may identify presymptomatic patients

“PET amyloid has historically largely been considered a positive or negative diagnostic test,” McMillan told MedPage Today. “But this study suggests that quantitative measurements of PET amyloid in pre-symptomatic individuals can be informative.” {read more here}